US Broker Ratings

Galapagos NV (GLPG) Stock Analysis: Revenue Growth Soars Despite a Challenging Landscape

Galapagos NV (NASDAQ: GLPG), the Belgium-based biotechnology firm, has captured investor attention with its impressive revenue growth of 1,093.20%. As a specialist in oncology and immunology,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 44% Potential Upside in Gene Editing Revolution

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering biotechnology company, stands at the forefront of the healthcare sector with its innovative CRISPR/Cas9 gene-editing platform. Headquartered in Zug,..

Astrana Health Inc. (ASTH) Investor Outlook: Analyst Ratings Suggest a 45% Upside Potential

Astrana Health Inc. (ASTH), a key player in the U.S. healthcare sector, is capturing investor attention with its promising growth potential and analyst ratings indicating a..

Xenon Pharmaceuticals Inc. (XENE) Stock Report: Exploring a Promising 18.67% Potential Upside

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a Canadian biotechnology powerhouse specializing in neuroscience therapeutics, has rapidly ascended as a compelling investment opportunity within the healthcare sector. With..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Exploring a 91% Potential Upside in Biotechnology

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery, leveraging cutting-edge technology to decode biology and..

National HealthCare Corporation (NHC) Stock Analysis: A Stable Healthcare Player with a 1.59% Dividend Yield

National HealthCare Corporation (NHC), a stalwart in the healthcare sector, offers investors a robust business model centered around medical care facilities. With a market capitalization of..

Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Exploring a Potential 39% Upside in the Booming Biotechnology Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is making waves in the biotechnology sector with its innovative approach to immune medicine. As a commercial-stage company, Adaptive Biotechnologies has..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a Potential 67% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find Azenta, Inc. (NASDAQ: AZTA) an intriguing prospect, especially given its potential upside of 67.17% based on the..

Neogen Corporation (NEOG) Stock Analysis: A 20% Upside Potential Despite Revenue Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a unique opportunity for investors. With a market..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with 57.30% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a promising player in the biotechnology sector, stands at the forefront of developing innovative therapies for cardiometabolic diseases. As a..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a Potential 44% Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, is capturing investor attention with a notable potential upside of 44.19% based on..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Evaluating a 34% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD) is a prominent player in the healthcare sector, focusing on medical care facilities across the United States. With a market..

Envista Holdings Corporation (NVST) Stock Analysis: Unveiling Growth Potential in the Dental Industry

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in medical instruments and supplies with a focus on dental products. With a..

Disc Medicine, Inc. (IRON): Investor Outlook Highlights Strong Buy Ratings and 55.95% Potential Upside

For investors eyeing opportunities in the biotechnology sector, Disc Medicine, Inc. (NASDAQ: IRON) presents a compelling case with its strong buy ratings and significant potential upside...

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential Upside of 286% in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with its innovative approach to cancer treatment. Specializing in immunotherapies, Janux..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Unveiling a Potential 47% Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector, especially for investors keen on exploring opportunities within the healthcare landscape. With its..

Celldex Therapeutics (CLDX): Investor Outlook on a Biotech with 79% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to treating severe inflammatory..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Unveiling a Promising 43.73% Potential Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), a pivotal player in the healthcare sector, is garnering significant attention from investors, and for good reason. Specializing in the development..

GRAIL, Inc. (GRAL) Stock Analysis: Potential 76.64% Upside with Innovative Cancer Detection Solutions

GRAIL, Inc. (GRAL) is making waves in the healthcare sector with its groundbreaking advancements in cancer diagnostics. As a commercial-stage healthcare company headquartered in Menlo Park,..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A 21% Upside Potential with Strong Buy Ratings

Kiniksa Pharmaceuticals International (NASDAQ: KNSA) has rapidly emerged as a noteworthy player in the biopharmaceutical sector, capturing investor attention with its robust growth metrics and promising..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds